Hot Features
프리미엄
Keros Therapeutics Inc (KROS)
NASDAQ
브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candida... Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis. 더 보기
| 기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.205 | 1.93670288144 | 10.585 | 11.2 | 10.43 | 836003 | 10.81428926 | CS |
| 4 | -0.65 | -5.68181818182 | 11.44 | 12.05 | 10.09 | 999554 | 10.94759429 | CS |
| 12 | -45.85 | -80.9498587571 | 56.64 | 72.37 | 9.775 | 1729066 | 15.94288827 | CS |
| 26 | -35.1 | -76.4872521246 | 45.89 | 72.37 | 9.775 | 961262 | 24.78084506 | CS |
| 52 | -52.62 | -82.9837565053 | 63.41 | 73 | 9.775 | 649462 | 32.7353634 | CS |
| 156 | -41.36 | -79.309683605 | 52.15 | 73 | 9.775 | 375301 | 36.8747072 | CS |
| 260 | -9.31 | -46.3184079602 | 20.1 | 88.8 | 9.775 | 283964 | 39.67394345 | CS |
TheFinalCD
1 월 전
retireat40
2 월 전
retireat40
2 월 전
Dennis14
2 월 전
Monksdream
5 월 전
Monksdream
1 년 전
